StockData
Boston Scientific Corp logo

Boston Scientific Corp

BSXNYSESurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 2, 2026Score 14/3055% below fair value
$41.98−1.01 (-2.35%)

Close on Nov 20, 2026Market cap $60.84BP/E 17.0Yield –

Boston Scientific Gross Total Debt by Quarter

Gross Total Debt (EBITDA Reconciliation Basis, $M) ($M)

Boston Scientific Gross Total Debt: $11,952M in Q3 2026, up 3.0% from a year earlier.

Latest, Q3 2026
11,952
Period ended Sep 30, 2026
Change on a year earlier
+3.0%
11,600 in Q3 2025
History
15 quarters
Since Q1 2023
Sources
15
Documents cited below

Where the Q3 2026 figure comes from

“Debt $ 11,952”

Source: BSX FY2026Q3 Financial & Operational Highlights Presentation ↗

Reported in Quarterly FOH Appendix C.

quarterly history

Hover a value to see the sentence it was read from; calculated values show their formula

Cite this data

StockData. (2026). Boston Scientific Gross Total Debt ($M), quarterly Q1 2023–Q3 2026 [Data set]. Compiled from Boston Scientific SEC filings and investor materials. https://stockdatahq.com/stocks/bsx/kpis/lev-gross-debt

See every metric in the Boston Scientific KPI table. Data updated Nov 4, 2026.

See a number that looks wrong?